Sirolimus-eluting stents suppress neointimal formation irrespective of metallic allergy.
about
Combination coating of chitosan and anti-CD34 antibody applied on sirolimus-eluting stents can promote endothelialization while reducing neointimal formation.Metal allergy to everolimus-eluting cobalt chromium stents confirmed by positive skin testing as a cause of recurrent multivessel in-stent restenosis.Long-Term Effects of Novel Combination Coating Anti-CD34 Antibody Applied on Sirolimus-Eluting Stents.
P2860
Sirolimus-eluting stents suppress neointimal formation irrespective of metallic allergy.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Sirolimus-eluting stents suppress neointimal formation irrespective of metallic allergy.
@en
Sirolimus-eluting stents suppress neointimal formation irrespective of metallic allergy.
@nl
type
label
Sirolimus-eluting stents suppress neointimal formation irrespective of metallic allergy.
@en
Sirolimus-eluting stents suppress neointimal formation irrespective of metallic allergy.
@nl
prefLabel
Sirolimus-eluting stents suppress neointimal formation irrespective of metallic allergy.
@en
Sirolimus-eluting stents suppress neointimal formation irrespective of metallic allergy.
@nl
P2093
P356
P1433
P1476
Sirolimus-eluting stents suppress neointimal formation irrespective of metallic allergy.
@en
P2093
Atsuhiko Yagishita
Gaku Nakazawa
Hirosada Yamamoto
Hiroyoshi Nakajima
Kazuhiro Hara
Kengo Tanabe
Shuji Ohtsuki
Yasutomi Higashikuni
P304
P356
10.1253/CIRCJ.72.893
P577
2008-06-01T00:00:00Z